A Spanish , Multicentre, Open-label, Observational Study to Assess Quality of Life and Satisfaction in Subjects Taking PecFent® for the Treatment of Breakthrough Cancer Pain (BTPc)
Observational Model: Cohort, Time Perspective: Prospective
Satisfaction will be assessed using a 4-point Likert scale.
Satisfaction will be assessed approximately 1 hour after each breakthrough pain (BTPc) episode treated with PecFent® from completion of titration through Day 7
Spain: Agencia Española de Medicamentos y Productos Sanitarios